Literature DB >> 3580873

Intracarotid infusions of protamine sulfate disrupt the blood-brain barrier of rabbits.

L J Strausbaugh.   

Abstract

This study examined the effect of intracarotid infusions of protamine sulfate on the blood-brain barrier of the rabbit. Evans blue, which binds tightly to serum albumin, served as the marker for blood-brain barrier disruption. Brains from 12 of 14 rabbits receiving 30-50 mg of protamine sulfate in an intracarotid infusion over 3 min demonstrated intense Evans blue-albumin staining in the distribution of the infused internal carotid artery. In contrast, brains from 5 animals receiving 0.9% saline and from 5 animals receiving 50 mg of protamine sulfate by the intravenous route showed no evidence of blood-brain barrier disruption. Premixing protamine sulfate with heparin prior to intracarotid administration greatly reduced or abolished Evans blue staining of the brain as did delayed administration of the marker dye. Thus, the interaction of the positively charged protamine molecule with the vascular endothelium of cerebral capillaries transiently alters the permeability of the blood-brain barrier in the rabbit.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3580873     DOI: 10.1016/0006-8993(87)90705-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

Review 1.  Effects of the chemical structure and the surface properties of polymeric biomaterials on their biocompatibility.

Authors:  You-Xiong Wang; John L Robertson; William B Spillman; Richard O Claus
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

2.  Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein.

Authors:  D Triguero; J B Buciak; J Yang; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

3.  Leakage of blood-retinal barrier due to damaging effect of protamine sulfate on the endothelium.

Authors:  W L Lin
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

4.  Protamine-mediated transport of albumin into brain and other organs of the rat. Binding and endocytosis of protamine-albumin complex by microvascular endothelium.

Authors:  W M Pardridge; J L Buciak; Y S Kang; R J Boado
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

Review 5.  Drug transport across the blood-brain barrier. III. Mechanisms and methods to improve drug delivery to the central nervous system.

Authors:  J B Van Bree; A G De Boer; M Danhof; D D Breimer
Journal:  Pharm World Sci       Date:  1993-02-19

6.  Effective intravenous therapy for neurodegenerative disease with a therapeutic enzyme and a peptide that mediates delivery to the brain.

Authors:  Yu Meng; Istvan Sohar; David E Sleat; Jason R Richardson; Kenneth R Reuhl; Robert B Jenkins; Gobinda Sarkar; Peter Lobel
Journal:  Mol Ther       Date:  2013-12-26       Impact factor: 11.454

7.  Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy.

Authors:  Shailendra Joshi; Aysegul Ergin; Mei Wang; Roberto Reif; Jane Zhang; Jeffrey N Bruce; Irving J Bigio
Journal:  J Neurooncol       Date:  2010-12-12       Impact factor: 4.130

8.  Changes in the distribution of anionic sites in brain micro-blood vessels with and without amyloid deposits in scrapie-infected mice.

Authors:  A W Vorbrodt; D H Dobrogowska; A S Lossinsky; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 9.  Magnetic nanoparticles for tumor imaging and therapy: a so-called theranostic system.

Authors:  Huining He; Allan David; Beata Chertok; Adam Cole; Kyuri Lee; Jian Zhang; Jianxin Wang; Yongzhuo Huang; Victor C Yang
Journal:  Pharm Res       Date:  2013-01-24       Impact factor: 4.200

10.  Immunocytochemical studies of protamine-induced blood-brain barrier opening to endogenous albumin.

Authors:  A W Vorbrodt; D H Dobrogowska; M Ueno; A S Lossinsky
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.